Your browser doesn't support javascript.
loading
Treatment of post-transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti-IL6R humanised monoclonal antibody Tocilizumab.
Sivapalaratnam, Suthesh; Linpower, Lisa; Sirigireddy, Bala; Agapidou, Alexandra; Jain, Susan; Win, Nay; Tsitsikas, Dimitris A.
Affiliation
  • Sivapalaratnam S; Haemoglobinopathy Service, Department of Haematology, Homerton University Hospital NHS Foundation Trust, London, UK.
  • Linpower L; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Sirigireddy B; QMUL, London, UK.
  • Agapidou A; Haemoglobinopathy Service, Department of Haematology, Homerton University Hospital NHS Foundation Trust, London, UK.
  • Jain S; Haemoglobinopathy Service, Department of Haematology, Homerton University Hospital NHS Foundation Trust, London, UK.
  • Win N; Haemoglobinopathy Service, Department of Haematology, Homerton University Hospital NHS Foundation Trust, London, UK.
  • Tsitsikas DA; Intensive Care Unit, Homerton University Hospital NHS Foundation Trust, London, UK.
Br J Haematol ; 186(6): e212-e214, 2019 09.
Article in En | MEDLINE | ID: mdl-31368112
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Erythrocyte Transfusion / Antibodies, Monoclonal, Humanized / Transfusion Reaction / Hemolysis / Anemia, Sickle Cell Limits: Adult / Humans / Male Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Erythrocyte Transfusion / Antibodies, Monoclonal, Humanized / Transfusion Reaction / Hemolysis / Anemia, Sickle Cell Limits: Adult / Humans / Male Language: En Year: 2019 Type: Article